Hybrid reference genome assembly for the archetypal Leishmania (Viannia) guyanensis bearing the dsRNA totivirus LRV1
Peter J. Myler, Gowthaman Ramasamy, Wesley C. Warren, Deborah E. Dobson, Stephen M. Beverley

TL;DR
This paper presents a detailed genome assembly for a Leishmania guyanensis line that could help understand how the parasite causes leishmaniasis.
Contribution
The novel contribution is a high-quality hybrid genome assembly for a Leishmania line expressing luciferase and carrying the LRV1 totivirus.
Findings
A high-quality hybrid genome assembly was created for Leishmania (Viannia) guyanensis line M4147.
The genome includes a firefly luciferase reporter gene and the totivirus LRV1, linked to parasite hypervirulence.
This reference genome will aid in studying the infectivity and pathogenesis of leishmaniasis.
Abstract
We report a high-quality hybrid genome assembly and annotation for a Leishmania (Viannia) guyanensis line (M4147) expressing a firefly luciferase reporter gene and bearing the totivirus LRV1 strongly implicated in parasite hypervirulence. This reference genome should facilitate the study of infectivity and pathogenesis of cutaneous and severe leishmaniasis.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Parameter | Value |
|---|---|
| LgyM4147Luc3 | |
| WHO code | MHOM/BR/75/M4147 |
| Source | Human, cutaneous |
| Provenance | Jean Patterson |
| Bioproject |
|
| Assembly accession number |
|
| Read data accession numbers | Illumina: |
| HGAP3 assembly | 167 unitigs |
| Chromosomes | 35 + Maxicircle |
| GC content | 57.9% |
| Assembly size | 32,544,702 bp |
| Protein-coding genes | 8,066 CDSs + 149 pseudogenes |
| RNA genes | 25 rRNAs, 77 tRNAs, 1,077 ncRNAs |
| Transposable elements | 53 TATEs + 14 SLACs |
| LRV1 accession number |
|
- —National Institute of Allergy and Infectious Diseaseshttp://dx.doi.org/10.13039/100000060
- —National Institute of Allergy and Infectious Diseaseshttp://dx.doi.org/10.13039/100000060
- —National Human Genome Research Institutehttp://dx.doi.org/10.13039/100000051
- —National Institute of Allergy and Infectious Diseases
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsResearch on Leishmaniasis Studies · Insect symbiosis and bacterial influences · Insect and Pesticide Research
ANNOUNCEMENT
The trypanosomatid parasite Leishmania (Viannia) guyanensis is transmitted by phlebotomine sand flies and causes American tegumentary leishmaniasis (ATL). These infections are primarily zoonotic, but cause a range of human diseases, from localized or disseminated cutaneous lesions to disfiguring mucocutaneous disease (1), with both parasite and host factors contributing to different clinical manifestations. We report a hybrid short- and long-read assembly of a WHO reference line bearing the archetypal protozoal dsRNA totivirus LRV1 (2, 3), which has been used extensively since 1991 for studies of LRV1 biology and RNA interference (4–6). The clonal line (LgyM4147-LUC3) sequenced here expresses high levels of firefly luciferase, facilitating in vivo bioluminescent analysis, including LRV1-driven metastasis (5–7). Previous assemblies of L. guyanensis using short-read (Illumina) data contained numerous sequence gaps (8); but the present hybrid assembly comprises 35 chromosomal contigs (with only 4 sequence gaps) and the mitochondrial kinetoplast maxicircle. The LRV1 dsRNA virus sequence was also revised (see Table 1).
Parasites were cultivated in Schneider’s medium at 26°C in sealed flasks (5), grown to late log phase (3–4 days), and harvested by centrifugation. Nuclei were purified (9) and extracted by two rounds of gentle phenol/chloroform extraction (10), yielding gDNA >20 kb. DNA was sheared using a Covaris instrument and size-selected (>12 kb) with the Blue Pippen system (Sage Science) to generate libraries using the SMRT (single molecule real time) bell template kit 1.0, according to the manufacturer’s protocol (Pacific Biosciences). These were sequenced on an RSII instrument (Pacific Biosciences) using P6-C4 sequencing chemistry with a “movie length” of 4 h on a total of four SMRT cells, producing a total of 654 k reads with a mean and N50 read lengths of 4,827 and 11,634 bp, respectively.
Unless otherwise stated, version 1 and default parameters were used for all software tools. After quality filtering SMRT sequences to 26.7× estimated coverage, de novo assembly was performed with HGAP version 3 (11). Assembled contigs were error-corrected using Quiver (12) to generate high-quality consensus sequences. 13.5M (100 bp paired-end) reads generated on an Illumina HiSeq2000 instrument previously (8) were quality-filtered using QIIME (13) and used to further polish the Quiver-corrected contigs by 10 iterations of ICORN v2 (14). The resultant 167 unitigs were scaffolded by alignment against the L. braziliensis M2904 genome (15) using ABACAS v2 (16), resulting in 35 pseudochromosomes and one maxicircle contig. Gaps (and missing ends) were filled using PBJelly v2 (17) followed by manual curation, yielding a final genome length of 32,544,702 bp, with only 4 gaps and 31 of the 70 chromosome ends reaching telomere-associated hexanucleotide sequences (15).
Automated annotation was subsequently performed using RATT (18), SNAP (19), Augustus (20), Aragorn v1.2.38 (21), and Infernal v1.1 (22), followed by manual annotation with BlastN (23) to identify transposable elements (TEs) (24). The number of protein-coding and RNA genes (Table 1) was similar to those found in other Leishmania genomes (15, 25).
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Borges AF, Gomes RS, Ribeiro-Dias F. 2018. Leishmania (Viannia) guyanensis in tegumentary leishmaniasis. Pathog Dis 76. doi:10.1093/femspd/fty 02529722820 · doi ↗ · pubmed ↗
- 2Widmer G, Patterson JL. 1991. Genomic structure and RNA polymerase activity in Leishmania virus. J Virol 65:4211–4215. doi:10.1128/JVI.65.8.4211-4215.19912072450 PMC 248857 · doi ↗ · pubmed ↗
- 3Guilbride L, Myler PJ, Stuart K. 1992. Distribution and sequence divergence of LRV 1 viruses among different Leishmania species. Mol Biochem Parasitol 54:101–104. doi:10.1016/0166-6851(92)90099-61518522 · doi ↗ · pubmed ↗
- 4Ro YT, Scheffter SM, Patterson JL. 1997. Hygromycin B resistance mediates elimination of Leishmania virus from persistently infected parasites. J Virol 71:8991–8998. doi:10.1128/JVI.71.12.8991-8998.19979371555 PMC 230199 · doi ↗ · pubmed ↗
- 5Lye L-F, Owens K, Shi H, Murta SMF, Vieira AC, Turco SJ, Tschudi C, Ullu E, Beverley SM. 2010. Retention and loss of RNA interference pathways in trypanosomatid protozoans. P Lo S Pathog 6:e 1001161. doi:10.1371/journal.ppat.100116121060810 PMC 2965760 · doi ↗ · pubmed ↗
- 6Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, Schutz F, Zangger H, Revaz-Breton M, Lye L-F, Hickerson SM, Beverley SM, Acha-Orbea H, Launois P, Fasel N, Masina S. 2011. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331:775–778. doi:10.1126/science.119932621311023 PMC 3253482 · doi ↗ · pubmed ↗
- 7Hartley M-A, Bourreau E, Rossi M, Castiglioni P, Eren RO, Prevel F, Couppié P, Hickerson SM, Launois P, Beverley SM, Ronet C, Fasel N. 2016. Leishmaniavirus-dependent metastatic leishmaniasis is prevented by nlocking IL-17A. P Lo S Pathog 12:e 1005852. doi:10.1371/journal.ppat.100585227658195 PMC 5033371 · doi ↗ · pubmed ↗
- 8Zakharova A, Albanaz ATS, Opperdoes FR, Škodová-Sveráková I, Zagirova D, Saura A, Chmelová L, Gerasimov ES, Leštinová T, Bečvář T, Sádlová J, Volf P, Lukeš J, Horváth A, Butenko A, Yurchenko V. 2022. Leishmania guyanensis M 4147 as a new LRV 1-bearing model parasite: Phosphatidate phosphatase 2-like protein controls cell cycle progression and intracellular lipid content. P Lo S Negl Trop Dis 16:e 0010510. doi:10.1371/journal.pntd.001051035749562 PMC 9232130 · doi ↗ · pubmed ↗
